Business
Cambridge Commodities appointment as distributor
Cambridge Commodities appointment as distributor.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \n \n RNS Number : 4282O\n OptiBiotix Health PLC\n 01 June 2020\n \n \n \n OptiBiotix Health plc\n \n \n (\n \n \"OptiBiotix\" or the \"Company\")\n \n \n Appointment of Cambridge Commodities as UK distributor\n Non-exclusive distribution agreement with ProBiotix Health Ltd\n \n \n OptiB\n i\n ot\n i\n x\n \n H\n ealth\n \n p\n l\n c\n \n (A\n I\n M\n :O\n P\n TI),\n \n a\n \n li\n f\n e\n \n sc\n i\n ences\n \n bu\n s\n i\n n\n ess\n \n d\n e\n ve\n l\n o\n p\n i\n n\n g\n \n c\n o\n m\n p\n o\n u\n n\n d\n s\n \n to\n \n tack\n l\n e\n \n o\n b\n esi\n t\n y,\n \n h\n i\n g\n h \n cholesterol, diabetes and skin care, announces\n that its wholly-owned subsidiary, ProBiotix Health Ltd. (\"ProBiotix\"), has entered \n into a non-exclusive distribution agreement with Cambridge Commodities Ltd (\"CCL\") for the distribution of LPLDL® and CholBiome®\n \n x3 \n \n in the UK\n .\n \n \n \n \n The agreement grants CCL a non-exclusive licence to distribute ProBiotix's specialty ingredient LPLDL®as well as the finished dietary supplement CholBiome®x3 for cholesterol and blood pressure reduction.\n \n CCL is one of the UK's leading specialty ingredients suppliers. The agreement extends the commercial reach of LPLDL® into new application areas where CCL has specific sector expertise, such as food and beverage, sports nutrition, health & wellbeing and beauty. The agreement builds on OptiBiotix's existing relationship with CCL (RNS: 28 January 2020) which led to the successful launch of SlimBiome® in Holland and Barrett.\n \n CCL is a supplier of nutritional ingredients to major UK retailers, and supplement companies. CCL has 10 sales offices which cover the UK, Europe, USA and South Africa with a multi-million pound annual turnover (https://www.cambridgecommodities.com/home.htm). LPLDL® and CholBiome®x3, are fully patented products and of natural origin developed by experts to provide documented significant reductions of LDL-cholesterol, as well as blood pressure levels which combined reduce the risk of Cardiovascular Disease multiplicatively. The products will be purchased from ProBiotix and distributed by CCL in UK. The agreement is based on minimum order quantities.\n \n \...